ESMO 2024

Area: Oncology

Location: Barcelona, Spain

Date: September 13 to September 17


Search in Scientific Content:
Date
Filters:
New develo
9:19

New developments in neurendocrine tumours

Presenter: Jennifer Chan
Oncology
Adjuvant P
4:21

Adjuvant Pembrolizumab Prolongs DFS Among Patients with High-Risk Muscle Invasive Urothelial Carcinoma

Presenter: Petros Grivas
Oncology
Randomized
4:18

Randomized Phase 3 Trial of Neoadjuvant Durvalumab plus Chemotherapy Followed by Radical Cystectomy and Adjuvant Durvalumab in Muscle-Invasive Bladder Cancer

Presenter: Petros Grivas
Oncology
Substantia
6:56

Substantial and Durable Overall and Intracranial Activity of Trastuzumab Deruxtecan in Previously Treated HER2-positive mBC Including a Large Cohort of Patients with Brain Metastases

Presenter: Giampaolo Bianchini
Oncology
Breast can
16:34

Breast cancer, metastatic highlights of the ESMO 2024 Congress

Presenter: Giampaolo Bianchini
Oncology
RCC highli
5:25

RCC highlights of ESMO 2024 Congress

Presenter: Camillo Porta
Oncology
Efficacy o
3:18

Efficacy of 177Lu-PNT2002 in PSMA-Positive mCRPC Following Progression on an Androgen-Receptor Pathway Inhibitor

Presenter: Oliver Sartor
Oncology
Prostate C
4:03

Prostate Cancer highlights of ESMO 2024 Congress

Presenter: Oliver Sartor
Oncology
Radiation
3:60

Radiation therapy for breast cancer can be safely shortened by changing technique

Presenter: Sofia Rivera
Oncology
Melanoma h
15:55

Melanoma highlights of the ESMO 2024 Congress

Presenter: Jessica Hassel
Oncology
Quadruplet
4:57

Quadruplet therapy is becoming the new standard of treatment - Multiple myeloma highlights at ESMO2024

Presenter: Xavier Leleu
Oncology
Lymphoma h
11:37

Lymphoma highlights of the ESMO 2024 Congress

Presenter: Maria Gomes da Silva
Oncology
LEAP-012 S
5:09

LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib + Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma

Presenter: Josep M. Llovet
Oncology
Pembrolizu
4:39

Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: Overall survival results from the randomized, double-blind, phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study

Presenter: Domenica Lorusso
Oncology
Lung cance
6:07

Lung cancer interception: New approaches to lung cancer screening and prevention

Presenter: Jianjun Zhang
Oncology
Genitourin
8:17

Genitourinary tumours, non-prostate highlights of the ESMO 2024 Congress

Presenter: Aristotelis Bamias
Oncology

Danube Symposium

2024-04-18 - 2024-05-20
Budapest, Hungary

ASH 2023

2023-12-09 - 2023-12-12
San Diego, United States

ESMO 2023

2023-10-20 - 2023-10-24
Madrid, Spain

ESMO Breast Cancer 2023

2023-05-11 - 2023-05-13
Berlin, Germany

EADO 2023

2023-04-20 - 2023-04-22
Rome, Italy

AACR 2023

2023-04-14 - 2023-04-19
Orlando, United States

SABCS 2022

2022-12-07 - 2022-12-10
Alcobendas, Afghanistan

ESMO 2022

2022-09-09 - 2022-09-13
Paris, France

ASCO 2022

2022-06-03 - 2022-06-07
Chicago, United States